by Asharq Al-Awsat English | May 27, 2016 | Health
Roche got a big boost on Friday following a successful clinical trial testing its new blood cancer drug, Gazyva, thus bracing visions for a new medicine that will be pivotal as the Swiss company fights the threat of biosimilar competition. Gazyva proved to be...